INFECTIOUS COMPLICATIONS IN PATIENTS (PTS) WITH HEMATOLOGICAL MALIGNANCIES AND MATCHED UNRELATED DONOR (MUD) CD3 DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)

被引：0
|
作者：
MATTIUZZI, G [1 ]
VARTIVARIAN, S [1 ]
PRZEPIORKA, D [1 ]
GIRALT, S [1 ]
ABISAID, D [1 ]
CORTES, J [1 ]
CHAMPLIN, R [1 ]
ANAISSIE, E [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,HOUSTON,TX 77025
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A337 / A337
页数：1
相关论文
共 50 条
  • [31] Survival after allogeneic bone marrow transplant (BMT) for adult acute lymphoblastic leukemia (ALL) is the same whether patients received either matched related donor (MRD) or matched unrelated donor (MUD) grafts.
    Absi, A
    Bolwell, BJ
    Sobecks, R
    Pohlman, B
    Andresen, S
    Rybicki, L
    Kalaycio, M
    BLOOD, 2003, 102 (11) : 490A - 490A
  • [32] BUCY3 as conditioning regimen in patients with hematologic malignancies undergoing allogeneic bone marrow transplantation (BMT).
    Milone, G
    Vasta, S
    Inghilterra, G
    Gioi, FL
    Peluso, R
    Indelicato, F
    Fiandaca, T
    Manenti, G
    Giustolisi, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S76 - S76
  • [33] Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies
    Baker, Melissa
    Wang, Hongkun
    Rowley, Scott D.
    Cai, Ling
    Pecora, Andrew L.
    Skarbnik, Alan
    Vesole, David H.
    Adler-Brecher, Barbara
    Kim, Daniel
    Donato, Michele L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (11) : 2047 - 2055
  • [34] CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens
    M Kalaycio
    L Rybicki
    B Pohlman
    R Sobecks
    E Ball
    D Cook
    S Andresen
    E Kuczkowski
    B Bolwell
    Bone Marrow Transplantation, 2005, 35 : 247 - 252
  • [35] COMPARISON OF IMMUNE RECONSTITUTION IN AUTOLOGOUS PURGED, HAPLOIDENTICAL T-CELL DEPLETED, AND SIBLING MATCHED ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR MALIGNANCY IN CHILDREN
    NELSON, SF
    CHAN, J
    MATTHAY, KK
    WARA, D
    COWAN, M
    PEDIATRIC RESEARCH, 1991, 29 (04) : A161 - A161
  • [36] A PRELIMINARY-ANALYSIS OF INTENSIFIED CONDITIONING (IC) FOLLOWED BY TRANSPLANTATION OF ALLOGENEIC BONE-MARROW (ALLOBMT) DEPLETED OF CD3+ CELLS USING HIGH-GRADIENT MAGNETIC SEPARATION (HGMS) IN PATIENTS (PTS) RECEIVING UNRELATED DONOR (UD) GRAFTS
    REECE, D
    THOMAS, T
    LANSDORP, P
    BARNETT, M
    NANTEL, S
    SUTHERLAND, H
    SPINELLI, J
    SHEPHERD, J
    KLINGEMANN, H
    PHILLIPS, G
    BLOOD, 1994, 84 (10) : A342 - A342
  • [37] Feasibility of second myeloablative therapy followed by matched unrelated donor (MUD) transplant for patients with hematologic malignancies who relapse after autologous bone marrow transplantation (ABMT)
    Redei, I
    Geller, RB
    OToole, K
    Devine, S
    Holland, HK
    Wingard, JR
    Yeager, AM
    BLOOD, 1996, 88 (10) : 3846 - 3846
  • [38] BONE-MARROW TRANSPLANTATION (BMT) FOR WISKOTT-ALDRICH SYNDROME (WAS) - COMPARISON OF UNRELATED DONOR (URD) BMT WITH RESULTS OF BMT USING MATCHED SIBLING DONORS (MSD) AND OTHER RELATED DONORS (ORD)
    FILIPOVICH, AH
    KOLLMAN, C
    ROWLINGS, P
    HOROWITZ, M
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 679 - 679
  • [39] Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies
    T Natazuka
    K Kajimoto
    R Ogawa
    S Imoto
    T Koizumi
    R Nishimura
    T Nakagawa
    Bone Marrow Transplantation, 1998, 21 : 815 - 819
  • [40] Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies
    Natazuka, T
    Kajimoto, K
    Ogawa, R
    Imoto, S
    Koizumi, T
    Nishimura, R
    Nakagawa, T
    BONE MARROW TRANSPLANTATION, 1998, 21 (08) : 815 - 819
12345